Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-23

Clinical Trial Update: Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical study evaluating the efficacy of Levagen+ for diabetic peripheral neuropathy; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levagen+

Snippet

Sponsor: RDC Clinical Pty Ltd | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: RECRUITING